Presentation is loading. Please wait.

Presentation is loading. Please wait.

Residual CV Risk in Patients With Dyslipidemia and Stable CAD

Similar presentations


Presentation on theme: "Residual CV Risk in Patients With Dyslipidemia and Stable CAD"— Presentation transcript:

1 Exploring the Latest Statin Clinical Data in CAD: How to Treat High-Risk Patients?

2 Residual CV Risk in Patients With Dyslipidemia and Stable CAD

3 Residual CV Risk in Major Statin Trials

4 CHD Events Occur in Patients Treated With Statins

5 Residual CVD Risk in Patients With Diabetes Treated With Statins

6 Patients With Established CVD

7 Residual Risk in Patients Treated With High- Intensity Statins

8 Many Issues at Play -- Use a Team Approach

9 Low-Dose vs High-Dose Statins

10 Win-Win With a Team Approach

11 Helping Patients Understand the Challenges

12 REAL-CAD

13 REAL-CAD: Primary Endpoint CV Death/MI/Ischemic Stroke/UA

14 Serial Changes in Lipid Parameters and hs-CRP

15 Importance of Targeting LDL-C

16 Genetics: Very Low LDL-C Only Benefit

17 Statin Rx in Patients With ASCVD

18 What Are Your Patients' Needs and Risks
What Are Your Patients' Needs and Risks? Pick the Right Statin for Your Patient

19 Statins, ASCVD, VA Hospitals

20 Create a System That Supports Your Knowledge

21 Abbreviations

22 Abbreviations (cont)


Download ppt "Residual CV Risk in Patients With Dyslipidemia and Stable CAD"

Similar presentations


Ads by Google